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Bronchoalveolar lavage using flexible fibreoptic bronchoscope was carried out in 50 patients
1-2½ yr after exposure to the ‘toxic gas’ at Bhopal. Thirty six patients in the analysis were
categorised into 3 groups (viz., mild, moderate and severe), depending upon the severity of
exposure. There was an increase in cellularity in the lower respiratory tract (alveolitis) of
the severely exposed patients (in both smokers and non-smokers), compared to normals
(P< 0.05). The increase in cellularity in severely exposed non-smokers was due to abnormal
accumulation of macrophages (P<0.01), and in severely exposed smokers, to macrophages
(P<0.01) and neutrophils (P<0.05). Mild and moderately exposed patients did not show
significant change in cellularity in lower respiratory tract, compared to normal individuals
(P>0.2). There was a trend towards increasing cellularity, as the severity increased
(P < 0.0001) and higher numbers of total cells were seen in severely exposed smokers, suggest-
ing that smoking is a risk factor. It appears, therefore, that subjects severely exposed to
the toxic gas at Bhopal may have a subclinical alveolitis characterised by accumulation
and possibly activation of macrophages in the lower respiratory tract. Smokers, who
were exposed to the gas had in addition, accumulation of neutrophils.
It may be recalled that leakage of over interstitial disease. However, previous stu-
40 tonnes of ‘toxic’ gas from an underground dies1 had shown that normal results on tests
storage tank of a pesticide plant at Bhopal of pulmonary function did not rule out alveo-
on 3rd December, 1984, resulted in the death litis. It is widely accepted that alveolitis is
of a large number of people due to acute pul- the essential feature of the pathogenesis of
monary oedema and respiratory failure. The chronic interstitial lung diseases and the
survivors had persisting respiratory symptoms alveolitis is responsible for the injury and
and it was suspected that a proportion of fibrosis of the alveolar walls2-5. The techni-
these patients might develop interstitial lung que of bronchoalveolar lavage6 (BAL) had
disease. The suspicion was due to the fact made it possible to understand the character
that some of the patients had symptoms and and function of the effector cells in alveolitis.
radiological findings suggestive of interstitial A study was therefore planned to evaluate
lung disease, though physiological investi- the trachea-bronchial tree and to obtain
gations did not show clear-cut evidence of samples of inflammatory and immune effector
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cells from the lower respiratory tract, using
the technique of bronchoalveolar lavage.
Material & Methods
Ail studies were carried out under pro-
tocols approved by the Indian Council of
Medical Research, New Delhi. The pro-
cedures to be performed were explained in
the local language and the consent was
obtained in each case. This study was done
1-2½ yr after exposure to the toxic gas.
Pre-lavage assessment and investigations :
Pre-lavage assessment and investigations of
each patient included detailed history, phy-
sical examination, a full-plate PA chest X-
ray examination, a 12 lead electrocardiogram,
total and differential leucocyte count in the
peripheral blood and pulmonary function
tests (using Transfer Test Model C, P. K.
Morgan Pvt. Ltd., Chatham, UK). Patients
with pre-existing lung diseases were excluded
from the study.
Bronchoalveolar lavage : Bronchoscopy and
bronchoalveolar lavages were carried out
as an out-patient procedure at Hamidia
Hospital, Bhopal, in 50 patients. Patients
were premeditated intravenously with valium
(5-10 mg) and intramuscularly with atropine
(0.8 mg). Four per cent xylocaine spray
was used to anaesthetise the oropharynx and
5 per cent dextrose was given intravenously
during the procedure. The flexible fibreop-
tic bronchoscope with an inner diameter of
2.6 mm (Olympus BF type IT 10, S. no.
2511484) was used for bronchoscopy and
bronchoalveolar lavage. Usually the trans-
nasal passage was used, but occasionally
the bronchoscope was passed transorally.
The lavages were usually done from three
subsegments viz., right middle lobe; lingula
and left lower lobe. The tip of the bron-
choscope was wedged in a subsegment BAL
was performed with 300 ml sterile 0.9 per
cent saline at room temperature. One hundred
millilitres of sterile saline in five 20 ml ali-
quots were infused through the fibreoptic
bronchoscope into each of the three lobes
in the lower respiratory tract. After each
aliquot was infused, the cells and lavage
fluids were recovered by gentle suction
using 50-100 mm water negative pressure
with an usual clinical suction apparatus
and collected in specimen traps (Chesebrough-
Ponds Ltd., Ireland). The fluid obtained by
lavage was pooled in a sterile plastic cup
(Falcon-Plastics, Oxnard, CA). The bron-
choscopy and bronchoalveolar lavage pro-
cedures were done under continuous cardiac
monitoring. Supplemental oxygen was ad-
ministered during and 1-2 h following lavage.
All individuals were observed for 3-4 h
after bronchoscopy. There were no compli-
cations during bronchoscopy and lavage.
Immediately after lavage, the fluid was
filtered through three layers of sterile surgical
gauze and the volume was measured accura-
tely. Cells were evenly resuspended by
repeated aspirations with a 10 ml pipette. An
aliquot was removed for determinations of
cell number and preparations of filters for
determinations of differential cell count.
Rest of the fluid was centrifuged and preser-
ved for biochemical and immunological
investigations. The cells recovered by lavage
were counted on a haemocytometer, using
the unconcentrated lavage fluid7 and expres-
sed as cells per 100 ml of recovered fluid.
The lavage cell differentials were deter-
mined using filtration method7,8. Nitrocel-
lulose filters 25 mm in diameter with 5.0 µm
pores (SMWP-025-00, Millipore Corpora-
tion, Bedford, MA) were pre-soaked in
absolute alcohol for 5 sec and mounted above
a paper pad (AP-10-025-00, Millipore Corp.),
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in a 15 ml graduated funnel with a fritted analysis. None of these subjects had respi-
glass base (XX-100-25-14, Millipore Corpora- ratory symptoms or abnormal physical find-
tion). The filter was then washed with 15 ml ings, and all had normal chest X-rays and
of 0.9 per cent sodium chloride. 2 x 105 lavage normal pulmonary function tests. None of
cells were added to the funnel and the filter
was washed with 15 ml of absolute alcohol.
The filters were then removed from the funnel
apparatus, mounted onto 25 x 75 mm mic- 
roscope slides using bell clips (Bell Pro-
ducts Co.).
the subjects were on any medication. Our
results in normal subjects in Madras are
comparable to those reported from Delhi9
and Western countries10.
Classification of severity of exposure : As
the degree of exposure to the gas may not
be the same in all individuals, the patients
were categorised into three groups depending
upon the severity of exposure. The three
categories were as follows :–
Cells collected on filters were stained with
haematoxylin and eosin. The filters mounted
on glass slides were washed in tap water (5
min), and distilled water (1 min) and stained
in Harris haematoxylin (30 sec). Filters were
‘blued’ by washing in lukewarm tap water
for at least 20 min. After ‘bluing’, filters were
dipped in 50 per cent ethanol (1 min), and
80 per cent ethanol (1 min), and counter-
stained in eosin (2.5 min). The filters were
then dipped in 3 changes of absolute alcohol
(1 min each), one change of 2-propanol (2
min) and three changes of xylene (1-2 min
each), until they are transparent and mounted
on 25 x 75 mm glass microscope slides under
glass coverslips using permount. Using oil
immersion of a microscope, alveolar macro-
phages, lymphocytes, neutrophils and eosi-
nophils were identified and 400 cells were
counted from each preparation for deriving
the differentials. Bronchial epithelial cells
counted were always less than 5 per cent.
(i) Severe exposure–If one of the mem-
bers of the family died due to the toxic gas
exposure or the patient had severe ophthal-
mic and respiratory symptoms, requiring
immediate medical help with assistance from
others, the patient was classified as having
severe exposure.
(ii) Moderate exposure–After exposure
to the gas, if the patient developed respira-
tory symptoms and required immediate
medical relief, the patient was classified as
having moderate exposure.
(iii) Mild exposure–After exposure, if
the patient developed respiratory symptoms,
but did not seek immediate medical relief
because of mild symptoms, the patient was
classified as having mild exposure.
Normal controls : Ideally, lavages should
have been done in normal individuals not
exposed to ‘toxic’ gas at Bhopal. However,
lavages could not be done in normal people
because of the difficulty in obtaining consent
from them. In the present study, therefore,
the results of lavage performed on 12 non-
smoking individuals from Madras (Vijayan,
Analysis : Fourteen patients were excluded
from analysis due to the following reasons
viz., poor recovery of BAL fluid (6); acute
respiratory infections (3); interstitial fibrosis
(2) ; prior bronchogram (1) ; old pulmonary
tuberculosis (1); and normal smoker (I).
The two patients with interstitial fibrosis
were excluded because one (20 yr female)
V.K., unpublished data) were used for admitted that she had respiratory disease
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prior to exposure to the gas. The second
patient (a 65 yr old female) was excluded Table I. Total and differential cell counts in lower
because she attributed all her symptoms to gas respiratory tract
exposure (unconvincing history) and showed (Data are mean ± SD)
pus in the tracho-bronchial tree during lavage
procedure. Group Total                                               
cells
All data between groups were compared (x 10
6/dl)
using the two tailed Students’ ‘t’-test and also
with Mann-Whitney U test, and the results   Normal
werefound to be similar. The trend Chi square (Madras) 14.4 83.6 14.3 0.9 1.3
test was applied to see whether the level of (n=12) ±6.5 ± 7 . 1  ± 7 . 0  ± 0 . 9  ± 1 . 2
exposure had any trend effect OR the number
of cells.
Results
All patients (n=36) included in the analysis
were males. Female patients were not will-
ing to undergo the procedure. The mean
age was 35.7±10.6 yr (range 18-60 yr).
There were 6 patients with mild exposure,
5 with moderate exposure and 25 with severe
exposure. Eight patients were smokers and
all of them had severe exposure. All mildly
exposed patients had normal chest X-rays
and pulmonary function. Three of five mode-
rately exposed patients had radiographic
abnormality of 1/0 (ILO, 1980 classifica-
tion”) and two had obstructive ventilatory
defect. Radiographic abnormalities of 1/0
or 1/1 were observed in 18 of 25 severely
exposed patients. Obstructive and restric-
tive ventilatory defects were observed in 8
patients each in severely exposed group.
The total and differential leucocyte counts
and electrocardiograms were within normal
limits in all subjects studied.
The mean values of total and differential
cell counts in mildly and moderately exposed
patients were not significantly different (P>
0.2) from Madras normals (Table I). Severely
exposed patients had a significantly elevated
Mild exposure 10.7 86.8 12.3 0.8 0
(n = 6) ±3.2   ±5.4  ±4.9  ±0.98
Moderate
exposure 20.6 92.6 6.6 0.6 0
(n = 5) ±4.3 ± 3 . 7  ± 3 . 4  ± 0 . 4
Severe
exposure 39.2* 87.0 10.7 1.7 0.5
(n=25) ±24.2 ± 9 . 4  ± 8 . 7  ± 2 . 4  ± 1 . 6
M, macrophages; L, lymphocytes; N, neutrophils;
E, eosinophils
*P<0.05 as compared to the normal group
(P<0.05) total cell count in the lower res-
piratory tract compared to Madras normals.
This was true whether all individuals or only
severely exposed non-smokers were conside-
red. However, the proportion of different
types of cells recovered was similar to that
of normals in all groups (P>0.2, normal
compared to all others).
The range of total cells (x 106/dl)
recovered from the lower respiratory tract
was 5.5 to 13.8 in mildly exposed, 13.8 to
25.3 in moderately exposed, 15.3 to 71 in
severely exposed (non-smokers) and 21 to
136 in severely exposed (smokers) patients.
Eleven of 17 (64.7%) severely exposed (non-
smokers) and 7 of 8 (87.5%) severely exposed
(smokers) had more than Z-fold increase in
cells in the lower respiratory tract, whereas
only one of 11 (9 %) mildly and moderately
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exposed patients had more than 2-fold in-
crease. With increasing severity of exposure,
there. was a tendency for a higher propor-
tion of patients to have increasing cellularity
in the lower respiratory tract and this trend
was statistically significant (P<0.0001).
The absolute numbers of different types of
cells (total cells times differential percentages)
are given in Table II. Among the inflamma-
tory and immune effector cells recovered
from the lower respiratory tract, macroph-
ages showed a significant rise in severely
exposed patients, compared to normals
(P<0.01). This was true whether all indi-
viduals or only non-smokers were considered.
There was also a significant rise in neutro-
phils in severely exposed patients who
continued to smoke tobacco (P<0.05).
Table II. Mean absolute values of inflammatory and
immune effector cells
cells
(x 106/dl)
M L N E
Normal 12.10 2.10 0.1 0.2
(n = 12) ±5.54 ±1.39 ±0.17 ±0.14
Mild exposure 9.38 1.33 0.07 0
(n = 6) ±3.12 ±0.47 ±0.08
Moderate exposure    19.08 1.38 0.16 0
(n = 5) ±4.09 ±0.89 ±0.11
Severe exposure 29.69* 3.93 0.56 0.19
(non-smokers) ±14.47 ±3.20 ±0.82 ±0.47
(n= 17)
Severe exposure 46.58* 2.49 0.50** 0.04
(smokers) ±37.48 ±2.17 ±0.38 ±0.11
(n = 8)
P values, * <0.01; l *<0.05 as compared to normals
Discussion
In severely exposed patients (both smokers
and non-smokers), there was a significant
increase in inflammatory and immune effector
cells in the lower respiratory tract. Accu-
mulation of inflammatory cells in the alveo-
lar structures is referred to as alveolitis12
and the observation of increased cells in
severely exposed patients suggest that a
proportion of these patients had alveolitis.
The increase in cellularity in severely exposed
non-smokers was due to abnormal accumula-
tion of macrophages, whereas in severely
exposed smokers it was due to macrophages
and neutrophils. An increase in macro-
phages and neutrophils in the lower respira-
tory tract of smokers has been described by
earlier workers as well 10.
Activated macrophages had been shown
to produce various mediators which can cause
injury to and fibrosis of the lung paren-
chyma13. The observation of increased num-
ber of macrophages in the lower respiratory
tract in non-smoking severely exposed
patients, even 1 to 2½ yr after exposure to
the gas, suggests that alveolitis in this group
of patients may have a deleterious effect on
lung parenchyma. Usually, two types of
cells are involved in alveolitis, such as mac-
rophage-lymphocytic alveolitis in sarcoido-
sis14 macrophage-neutrophilic alveolitis in
idiopathic interstitial fibrosis15 and macro-
phage-eosinophilic alveolitis in Tropical
Eosinophilial6. However, a predominant
increase in macrophages had been described
in siIicosis17 and respiratory bronchiolitisl8.
Soon after exposure to the toxic gas, an
increase in neutrophils varying from 72 to
98 per cent in BAL had been reported19. The
occurrence of increased neutrophils in the
lower respiratory tract Soon after exposure19,
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and the observation of increased macro-
phages 1-2½ yr after exposure in the present
study may be similar to the observation in
mouse lung exposed to short Crocidolite
asbestos fibres in which there was a rapid
elevation of polymorphonuclear leucocytes,
followed by a decline in polymorphonuclear
leucocytes and a significant increase in alveo-
lar macrophages between 5 days and 8 weeks,
though it produced only minimal lung injury
and fibrosis20. Similar increase in macro-
phages in BAL were reported in other
experimental studies21,22.
It had been recently demonstrated in non-
smokers with long-term occupational
exposure to inorganic dusts and functional
evidence of interstitial diseases (asbestosis,
coal workers’ pneumoconiosis and silicosis),
that the inflammation in the lower respira-
tory tract was dominated by alveolar macro-
phages23. The single exposure of large
amounts of the toxic gas in our subjects has
also resulted in an exaggerated number of
alveolar macrophages in the lower respira-
tory tract, especially in severely exposed
patients. Though the occurrence of increased
numbers of alveolar macrophages may be
non-specific in character, the demonstration
that activated alveolar macrophages in various
occupational lung diseases are capable of
spontaneously releasing exaggerated amounts
of oxygen radicals (O2
– and H2O2), fibro-
nectin and alveolar macrophage derived
growth factor23 suggests that long-term
follow up of toxic gas exposed patients
is essential to know whether the expanded
numbers of alveolar macrophages are ‘acti-
vated’ and if so, cause any injury to the lung
parenchyma.
The increasing cellularity in the lower
respiratory tract, as the severity of exposure
increases and also the higher total cells in
severely exposed smokers compared to non-
smokers, suggest that smoking is a risk factor.
It was also further observed that the severely
exposed smokers had a significant increase
of neutrophils in the lower respiratory tract.
Recent studies13,24 had shown that activated
macrophages and neutrophils in the lower
respiratory tract can release mediators which
were toxic to the pulmonary tissue resulting
in permanent destructive changes. In view
of the possibility that a portion of the in-
creased alveolar macrophages and/or neutro-
phils (and/or their mediators) may be in
direct contact with small airway epithelium25,
and some of these patients had already obs-
tructive ventilatory defect, these cells/media-
tors may further damage the epithelium,
resulting in progressive chronic obstructive
lung disease. Health education of the commu-
nity to avoid any type of pollution such as
smoking tobacco, domestic and environ-
mental pollutions is essential to prevent the
early development of chronic lung diseases
in these patients. Similarly, the role of ste-
roids in suppressing alveolitis in severely
exposed patients has also to be critically
evaluated.
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